In CSF studies, elevated tau concentrations have been observed in HD patients, with correlations between tau levels and cognitive and motor deficits, indicating a potential role for tau in CSF as a biomarker for HD-related psychiatric symptoms [113]. Here, MAPT is linked to Huntington disease.